Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacementRaniero Chimienti, Lorenzo Piemonti, S. Torchio et al.|Cell Reports|2022Cited by 33
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients’ survival and long COVIDMaddalena Noviello, Chiara Bonini, Elisa Cantarelli et al.|Frontiers in Immunology|2024Cited by 12
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I−/− iPSC-derived β cells for cell therapy of type 1 diabetesRaniero Chimienti, Lorenzo Piemonti, Tania Baccega et al.|Cytotherapy|2020Cited by 2
Blockade of CD155 and CD276 by Monoclonal Antibodies Fosters Immune Tolerance and Promotes Stable Engraftment of iPSC-Derived Islets in Allogeneic Humanized MiceGabriel Siracusano, Raniero Chimienti, F. Deambrogio et al.|Transplant International|2025Cited by 1
02-2: BREAKING IMMUNE EVASION: NK CELL SURVEILLANCE OF HYPOIMMUNOGENIC IPSC-DERIVED PANCREATIC ISLETS DURING VIRAL INFECTIONS.Gabriel Siracusano, Lorenzo Piemonti, Raniero Chimienti et al.|Transplantation|2025Cited by 1